Product
CICLOFOSFAMIDA (INYECTABLE)
Code 16687 · Official unit: AMPOLLA
$ 4.229.503
Reported spend
94Contracts
13Buying agencies
9Suppliers
102Items bought2006–2026
The Uruguayan state bought CICLOFOSFAMIDA (INYECTABLE) across 94 awards between 2006 and 2026. 13 agencies took part. The agency that bought most is NO VIGENTE Instituto Nacional del Cáncer. The supplier that sold most is FARMACO URUGUAYO S.A..
Purchases by year
Who buys it
Agencies that bought this product most often.
- NO VIGENTE Instituto Nacional del Cáncer$ 1,2 M Profile
- Dirección Nacional de Sanidad de las Fuerzas Armadas$ 265.709 Profile
- Centro Auxiliar de Bella Unión$ 144.047 Profile
- Hospital Maciel$ 78.281 Profile
- Dirección Nacional de Sanidad Policial$ 25.000 Profile
- Hospital de Clínicas$ 18.288 Profile
- Centro Departamental de Durazno$ 10.390 Profile
- NO VIGENTE Hospital Maciel$ 7.900 Profile
- NO VIGENTE Centro Departamental de Salto$ 5.300 Profile
- Instituto Nacional del Cáncer$ 2.580 Profile
- NO VIGENTE Centro Departamental de Artigas$ 250 Profile
Who sells it
Suppliers that sold this product to the state most often.
- FARMACO URUGUAYO S.A.$ 2,8 M Profile
- LABORATORIO BIO SHAR S.R.L.$ 1,2 M Profile
- SUMINISTROS MEDICOS S A$ 128.914 Profile
- RINQUE PHARMA S.A.$ 65.000 Profile
- QUIMICA ARISTON URUGUAY S.A.$ 34.410 Profile
- RINQUE PHARMA S.A.$ 26.768 Profile
- SUMINISTROS MEDICOS S A$ 15.133 Profile
- ABC PROMO FARMA SRL.$ 2.100 Profile
- FARMACO URUGUAYO S.A.$ 1.910 Profile
Supplier concentration
How few suppliers account for this product's purchases: few suppliers signals a captive market.
Price dispersion
Unit-price range per currency and unit (p25 – p50 – p95). The wider the bar, the more what's paid varies.
Price reference
Price distribution per unit and currency over the last 36 months — the same baseline the price flags use.
| Unit | Typical (median) | Usual range | Comparables |
|---|---|---|---|
| UYU · ampolla | $ 1 | $ 1 – 498 | 31 |